Allogene Therapeutics (ALLO) Revenue (2021 - 2024)
Allogene Therapeutics (ALLO) reported Revenue of $22000.0 for Q1 2024, down 26.67% on a YoY basis from $30000.0 in Q2 2023, and up 4.76% sequentially from $21000.0 in Q4 2023.
Allogene Therapeutics (ALLO) Revenue (2021 - 2024) Analysis & Trends
Allogene Therapeutics (ALLO) has 4 years of Revenue data on file, last reported at $22000.0 in Q1 2024.
- For the quarter ending Q1 2024, Revenue fell 26.67% year-over-year to $22000.0; the trailing twelve-month figure through Dec 2024 stood at $22000.0 (down 76.84% YoY), and the FY2024 full-year result was $22000.0, down 76.84% from the prior year.
- Revenue advanced to $22000.0 in Q1 2024, from $21000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $75.7 million in Q4 2021 to a low of $21000.0 in Q4 2023.
- A 4-year average of $8.8 million and a median of $30000.0 in 2023 frame the typical range for Revenue.
- Peak annual rise in Revenue reached 45.45% in 2022, while the deepest fall reached 99.97% in 2022.
- Tracing ALLO's Revenue over 4 years: stood at $75.7 million in 2021, then plunged by 99.97% to $26000.0 in 2022, then retreated by 19.23% to $21000.0 in 2023, then climbed by 4.76% to $22000.0 in 2024.
- Business Quant data shows ALLO's Revenue at $22000.0 in Q1 2024, $21000.0 in Q4 2023, and $22000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Allogene Therapeutics | 421.71 Mn | 421.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 39,000.00 |
| Dec 31, 2021 | 75.65 Mn |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 44,000.00 |
| Mar 31, 2021 | 38.35 Mn |